Literature DB >> 17111254

Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States).

Chiaojung J Tsai1, Barbara A Cohn, Piera M Cirillo, David Feldman, Frank Z Stanczyk, Alice S Whittemore.   

Abstract

OBJECTIVE: To investigate the relation of sex hormone levels in young adults to subsequent prostate cancer risk.
METHODS: From 1959 to 1967, the Child Health and Development Studies collected sera from 10,442 men (median age: 34 years) and followed them for a median of 32 years. In this analysis, we selected 119 African-Americans and 206 Caucasians diagnosed with prostate cancer during the follow-up period. Two prostate cancer-free men were chosen to match each prostate cancer case on race and birth year. We compared the levels of testosterone, estradiol, and sex hormone-binding globulin in cases to those of their matched controls using conditional logistic regression.
RESULTS: There was no significant association between absolute levels of sex hormones in youth and prostate cancer risk in either race. However, among Caucasians, but not African-Americans, prostate cancer risk was positively associated with the ratio of total testosterone to total estradiol (odds ratio relating the fourth to the first quartile: 3.01; 95% confidence interval: 1.42-6.39).
CONCLUSIONS: The association between testosterone to estradiol ratio and prostate cancer risk in young Caucasians is consistent with similar findings in older Caucasians. The absence of this association in African-Americans needs confirmation in other data involving larger numbers of African-Americans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111254     DOI: 10.1007/s10552-006-0052-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

Review 1.  A review of African American-white differences in risk factors for cancer: prostate cancer.

Authors:  Irina Mordukhovich; Paul L Reiter; Danielle M Backes; Leila Family; Lauren E McCullough; Katie M O'Brien; Hilda Razzaghi; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2010-12-24       Impact factor: 2.506

2.  High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.

Authors:  Zakaria Y Abd Elmageed; Krzysztof Moroz; Sudesh K Srivastav; Zhide Fang; Byron E Crawford; Krishnarao Moparty; Raju Thomas; Asim B Abdel-Mageed
Journal:  Carcinogenesis       Date:  2013-05-08       Impact factor: 4.944

3.  Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Ther Adv Urol       Date:  2011-06

4.  Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.

Authors:  Amanda Black; Paul F Pinsky; Robert L Grubb; Roni T Falk; Ann W Hsing; Lisa Chu; Tamra Meyer; Timothy D Veenstra; Xia Xu; Kai Yu; Regina G Ziegler; Louise A Brinton; Robert N Hoover; Michael B Cook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-01       Impact factor: 4.254

5.  Age-specific physical activity and prostate cancer risk among white men and black men.

Authors:  Steven C Moore; Tricia M Peters; Jiyoung Ahn; Yikyung Park; Arthur Schatzkin; Demetrius Albanes; Albert Hollenbeck; Michael F Leitzmann
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

Review 6.  Prostate cancer: is it time to expand the research focus to early-life exposures?

Authors:  Siobhan Sutcliffe; Graham A Colditz
Journal:  Nat Rev Cancer       Date:  2013-01-31       Impact factor: 60.716

7.  Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis.

Authors:  A Richard; S Rohrmann; L Zhang; M Eichholzer; S Basaria; E Selvin; A S Dobs; N Kanarek; A Menke; W G Nelson; E A Platz
Journal:  Andrology       Date:  2014-03-20       Impact factor: 3.842

8.  Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Jeannette M Schenk; Cathee Till; Ann W Hsing; Frank Z Stanczyk; Zhihong Gong; Marian L Neuhouser; Juergen K Reichardt; Ashraful M Hoque; William D Figg; Phyllis J Goodman; Catherine M Tangen; Ian M Thompson
Journal:  Cancer Causes Control       Date:  2015-11-20       Impact factor: 2.506

9.  Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.

Authors:  Jasmeet K Gill; Lynne R Wilkens; Michael N Pollak; Frank Z Stanczyk; Laurence N Kolonel
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

10.  Prenatal Diethylstilbestrol Exposure and Cancer Risk in Males.

Authors:  William C Strohsnitter; Marianne Hyer; Kimberly A Bertrand; Andrea L Cheville; Julie R Palmer; Elizabeth E Hatch; Kjersti M Aagaard; Linda Titus; Iris L Romero; Dezheng Huo; Robert N Hoover; Rebecca Troisi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-16       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.